396 related articles for article (PubMed ID: 22701633)
21. [A HLA-A2-restricted-CTL epitope variation at the N-terminal of HCV helicase and the immune response of CTLs].
Guo HZ; Wang WL; Wang T
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):325-7. PubMed ID: 15193229
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of HLA-A*02-restricted Hantaan virus multiple-antigenic peptide for CD8
Ma Y; Tang K; Zhang Y; Zhang C; Zhang Y; Jin B; Ma Y
Virol J; 2020 Jan; 17(1):15. PubMed ID: 32005266
[TBL] [Abstract][Full Text] [Related]
23. Development of a dendritic cell vaccine encoding multiple cytotoxic T lymphocyte epitopes targeting hepatitis C virus.
Zhou Y; Zhao F; Chen L; Ma L; Wang Y; He Y; Ma Z; Liu H; Guo Y; Zhang Y; Yao Z; Hao C; Jia Z
Int J Mol Med; 2013 Oct; 32(4):901-9. PubMed ID: 23934073
[TBL] [Abstract][Full Text] [Related]
24. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
[TBL] [Abstract][Full Text] [Related]
25. Peptide FLNPDVLDI of heparanase is a novel HLA-A2-restricted CTL epitope and elicits potent immunological antitumor effects in vitro with an 8-branched design.
Zhang J; Yang J; Fan D; Tao H; Wang H; Yu T
Oncol Rep; 2013 May; 29(5):1955-61. PubMed ID: 23503586
[TBL] [Abstract][Full Text] [Related]
26. In vitro generated cytolytic T lymphocytes reactive against head and neck cancer recognize multiple epitopes presented by HLA-A2, including peptides derived from the p53 and MDM-2 proteins.
Asai T; Storkus WJ; Mueller-Berghaus J; Knapp W; DeLeo AB; Chikamatsu K; Whiteside TL
Cancer Immun; 2002 Apr; 2():3. PubMed ID: 12747748
[TBL] [Abstract][Full Text] [Related]
27. Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.
Kurokohchi K; Akatsuka T; Pendleton CD; Takamizawa A; Nishioka M; Battegay M; Feinstone SM; Berzofsky JA
J Virol; 1996 Jan; 70(1):232-40. PubMed ID: 8523531
[TBL] [Abstract][Full Text] [Related]
28. New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.
Wang Y; Takao Y; Harada M; Yutani S; Ide T; Sata M; Itoh K; Yamada A
Microbiol Immunol; 2006; 50(11):857-65. PubMed ID: 17116980
[TBL] [Abstract][Full Text] [Related]
29. Generation of functional CD8+ T cells by human dendritic cells expressing glypican-3 epitopes.
O'Beirne J; Farzaneh F; Harrison PM
J Exp Clin Cancer Res; 2010 May; 29(1):48. PubMed ID: 20465843
[TBL] [Abstract][Full Text] [Related]
30. Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.
Duan Z; Guo J; Huang X; Liu H; Chen X; Jiang M; Wen J
J Med Virol; 2015 Jul; 87(7):1077-89. PubMed ID: 25777343
[TBL] [Abstract][Full Text] [Related]
31. Identification of an HLA-A*0201-restrictive CTL epitope from MUC4 for applicable vaccine therapy.
Wu J; Wei J; Meng K; Chen J; Gao W; Zhang J; Xu Z; Miao Y
Immunopharmacol Immunotoxicol; 2009; 31(3):468-76. PubMed ID: 19555216
[TBL] [Abstract][Full Text] [Related]
32. Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3.
Yang S; Kittlesen D; Slingluff CL; Vervaert CE; Seigler HF; Darrow TL
J Immunol; 2000 Apr; 164(8):4204-11. PubMed ID: 10754316
[TBL] [Abstract][Full Text] [Related]
33. Mapping of cytotoxic T lymphocytes epitopes in E7 antigen of human papillomavirus type 11.
Xu Y; Zhu KJ; Chen XZ; Zhao KJ; Lu ZM; Cheng H
Arch Dermatol Res; 2008 Jun; 300(5):235-42. PubMed ID: 18299861
[TBL] [Abstract][Full Text] [Related]
34. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody].
Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY
Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545
[TBL] [Abstract][Full Text] [Related]
35. [Impaired non-viral specific immune function of dendritic cell does not interfere with clearance and cytotoxic T lymphocyte response to HBV or HCV].
Fan CL; Chen HS; Li RB; Wang SX; Cong X; Fei R; Jiang D; Wang Y; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):67-71. PubMed ID: 14980100
[TBL] [Abstract][Full Text] [Related]
36. Evolution of viral quasispecies in four dominant HlA-A2 restricted T cell epitopes is not a major reason for viral persistence in interferon-treated patients with chronic hepatitis C.
Pingel S; Weyer S; Galle PR; Löhr HF
J Med Virol; 2002 Apr; 66(4):472-80. PubMed ID: 11857524
[TBL] [Abstract][Full Text] [Related]
37. Identification of Novel Cytotoxic T Lymphocyte Epitopes of Drug- Resistance Related Protein InhA from Mycobacterium tuberculosis.
Li D; Dou Z; Wu Y; Qi Y; Chen J; Gao Y
Protein Pept Lett; 2020; 27(11):1141-1150. PubMed ID: 32370703
[TBL] [Abstract][Full Text] [Related]
38. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen.
Chung MK; Yoon H; Min SS; Lee HG; Kim YJ; Lee TG; Lim JS; Kim CM; Park SN
J Immunother; 1999 Jul; 22(4):279-87. PubMed ID: 10404429
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of a human agonist cytotoxic T-lymphocyte epitope of human prostate-specific antigen.
Terasawa H; Tsang KY; Gulley J; Arlen P; Schlom J
Clin Cancer Res; 2002 Jan; 8(1):41-53. PubMed ID: 11801539
[TBL] [Abstract][Full Text] [Related]
40. Dendritic cell-mediated, DNA-based vaccination against hepatitis C induces the multi-epitope-specific response of humanized, HLA transgenic mice.
Mishra S; Lavelle BJ; Desrosiers J; Ardito MT; Terry F; Martin WD; De Groot AS; Gregory SH
PLoS One; 2014; 9(8):e104606. PubMed ID: 25111185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
